Metabolic interaction between cancer-associated fibroblasts (CAFs) and colorectal cancer (CRC) cells plays a major role in CRC progression. However, little is known about lipid alternations in CAFs and how these metabolic reprogramming affect CRC cells metastasis. Here, we uncover CAFs conditioned medium (CM) promote the migration of CRC cells compared with normal fibroblasts CM. CAFs undergo a lipidomic reprogramming, and accumulate more fatty acids and phospholipids. CAFs CM after protein deprivation still increase the CRC cells migration, which suggests small molecular metabolites in CAFs CM are responsible for CRC cells migration. Then, we confirm that CRC cells take up the lipids metabolites that are secreted from CAFs. Fatty acids synthase (FASN), a crucial enzyme in fatty acids synthesis, is significantly increased in CAFs. CAF-induced CRC cell migration is abolished by knockdown of FASN by siRNA or reducing the uptake of fatty acids by CRC cells by sulfo-N-succinimidyloleate sodium in vitro and CD36 monoclonal antibody in vivo. To conclude, our results provide a new insight into the mechanism of CRC metastasis and suggest FASN of CAFs or CD36 of CRC cells may be potential targets for anti-metastasis treatment in the future.
This study aimed to explore the association of red cell distribution width to albumin ratio (RAR) with all-cause mortality in ICU-NAFLD patients, to evaluate RAR as a prognostic tool. Patients were stratified into four groups, with 365- and 28-day all-cause mortality as primary and secondary endpoints. The Kaplan-Meier analysis compared survival across groups, while Cox regression and restricted cubic spline (RCS) evaluated associations between red cell distribution width-to-albumin ratio (RAR) and outcomes. The predictive performance of RAR was quantified using receiver operating characteristic (ROC) curves. A nomogram predicting treatment response was developed and internally validated via bootstrap resampling. Calibration and clinical utility were further assessed by Hosmer-Lemeshow test and decision curve analysis (DCA). A total of 590 patients with NAFLD were enrolled. Higher levels of the RAR index were correlated with an increased risk of 28- and 365-day all-cause mortality, as indicated by the K-M curves (log-rank P < 0.001). Multivariate Cox proportional risk analysis, after adjusting for confounding factors, displayed that high RAR levels were associated with an increased risk of 28-day mortality (HR 1.82[95%CI [1.10,3.04], P = 0.021) and 365-day mortality (HR 1.58 [95%CI[1.10,2.28], P = 0.014), with a nonlinear relationship observed for long-term risk (P-overall < 0.001, P-nonlinear = 0.046). Finally, the combination of RAR, TBiL, Scr, and INR had a good diagnostic efficiency for NAFLD (sensitivity: 72.93%, specificity: 69.44%, AUC: 0.759). The H-L test and DCA showed a certain alignment between predicted and actual results (accuracy of 0.733 and a Kappa statistic of 0.490). Elevated RAR independently predicts increased 28- and 365-day mortality in critically ill NAFLD patients. The combination of RAR with routine biomarkers (AUC = 0.759) improves mortality prediction. Routine monitoring of this simple, cost-effective ratio may aid in risk stratification and early intervention for high-risk ICU patients with NAFLD.
BACKGROUND: The Hedgehog (Hh) signaling pathway has recently been reported to be associated with the prognosis of digestive system cancers. However, the results are inconsistent. OBJECTIVE: This study aimed to investigate the association between Hh p